{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:59:04Z","timestamp":1779206344778,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024J3049"],"award-info":[{"award-number":["2024J3049"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jtct.2024.08.022","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T20:22:27Z","timestamp":1725394947000},"page":"1213.e1-1213.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Uniform Graft-versus-Host Disease Prophylaxis using Post-Transplantation Cyclophosphamide, Methotrexate, and Cyclosporine following Peripheral Blood Hematopoietic Stem Cell Transplantation from Matched and Haploidentical Donors for Transfusion-Dependent Thalassemia: A Retrospective Report from the Bone Marrow Failure Working Group of Hunan Province, China"],"prefix":"10.1016","volume":"30","author":[{"given":"Susu","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangchun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3119-7497","authenticated-orcid":false,"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2024.08.022_bib0001","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","article-title":"Thalassaemia","volume":"399","author":"Kattamis","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2024.08.022_bib0002","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41591-022-01906-z","article-title":"CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric \u03b20\/\u03b20 transfusion-dependent \u03b2-thalassemia","volume":"28","author":"Fu","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2024.08.022_bib0003","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1038\/s41409-021-01461-0","article-title":"HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe","volume":"56","author":"Oikonomopoulou","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0004","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/bloodadvances.2019000291","article-title":"Related and unrelated donor transplantation for \u03b2-thalassemia major: results of an international survey","volume":"3","author":"Li","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.08.022_bib0005","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2024.08.022_bib0006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bjh.18520","article-title":"Haploidentical transplant for paediatric patients with severe thalassaemia using post-transplant cyclophosphamide and methotrexate: a prospectively registered multicentre trial from the Bone Marrow Failure Working Group of Hunan Province, China","volume":"200","author":"Hu","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2024.08.022_bib0007","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/ejh.13825","article-title":"Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high risk","volume":"109","author":"Mehta","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2024.08.022_bib0008","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1038\/s41409-021-01302-0","article-title":"Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide","volume":"56","author":"Oostenbrink","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0009","doi-asserted-by":"crossref","DOI":"10.1177\/0963689721994808","article-title":"Co-transplantation of haploidentical stem cells and a dose of unrelated cord blood in pediatric patients with thalassemia major","volume":"30","author":"Wang","year":"2021","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.21037\/tp-20-415","article-title":"Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts","volume":"10","author":"Huang","year":"2021","journal-title":"Transl Pediatr"},{"key":"10.1016\/j.jtct.2024.08.022_bib0011","doi-asserted-by":"crossref","first-page":"e14466","DOI":"10.1111\/petr.14466","article-title":"Addition of ruxolitinib in Graft-versus-Host disease prophylaxis for pediatric beta-Thalassemia major patients after allogeneic stem cell transplantation: a retrospective cohort study","volume":"27","author":"Hong","year":"2023","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0012","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2020.01.002","article-title":"Hematopoietic stem cell transplantation for severe thalassemia patients from haploidentical donors using a novel conditioning regimen","volume":"26","author":"Anurathapan","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0013","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2012-03-417998","article-title":"A novel conditioning regimen improves outcomes in \u03b2-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.08.022_bib0014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0016","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/bmt.2015.293","article-title":"Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010","volume":"51","author":"Baronciani","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0017","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41409-022-01786-4","article-title":"Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major","volume":"57","author":"Santarone","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0018","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/bloodadvances.2016004119","article-title":"ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia","volume":"1","author":"Faulkner","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.08.022_bib0019","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/bmt.2016.7","article-title":"Hematopoietic stem cell transplantation for homozygous \u03b2-thalassemia and \u03b2-thalassemia\/hemoglobin E patients from haploidentical donors","volume":"51","author":"Anurathapan","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0020","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2019.02668","article-title":"Mechanisms of graft-versus-host disease prevention by post-transplantation cyclophosphamide: an evolving understanding","volume":"10","author":"Nunes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2024.08.022_bib0021","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.jtct.2021.02.014","article-title":"Haploidentical peripheral stem cell transplantation for young patients with severe aplastic anemia using post-transplantation cyclophosphamide and methotrexate","volume":"27","author":"Yang","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.08.022_bib0022","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.hemonc.2020.01.003","article-title":"Haploidentical stem cell transplant with post-transplantation cyclophosphamide and mini-dose methotrexate in children","volume":"13","author":"Medina","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2024.08.022_bib0023","doi-asserted-by":"crossref","first-page":"e13876","DOI":"10.1111\/petr.13876","article-title":"Prediction, management, and prognosis of mixed chimerism after hematopoietic stem cell transplantation in transfusion-dependent pediatric thalassemia patients","volume":"24","author":"Chen","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0024","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/bmt.2017.231","article-title":"Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide","volume":"53","author":"Fouzia","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0025","doi-asserted-by":"crossref","first-page":"e14648","DOI":"10.1111\/petr.14648","article-title":"Effect of serum panel reactive antibodies on allogeneic hematopoietic stem cell transplantation in pediatric thalassemia patients: a single-center experience","volume":"28","author":"Malbora","year":"2024","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3406230","article-title":"the targets of monoclonal and alloantibodies defined","volume":"2017","author":"El-Awar","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jtct.2024.08.022_bib0027","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.bbmt.2015.05.001","article-title":"Complement-binding donor-specific anti-HLA antibodies and risk of primary graft failure in hematopoietic stem cell transplantation","volume":"21","author":"Ciurea","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.022_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.916200","article-title":"Donor specific HLA antibody in hematopoietic stem cell transplantation: implications for donor selection","volume":"13","author":"Krummey","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2024.08.022_bib0029","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12185-020-03055-w","article-title":"Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation","volume":"113","author":"Lertkovit","year":"2021","journal-title":"Int J Hematol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724006225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724006225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T03:48:23Z","timestamp":1764560903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724006225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2666636724006225"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.08.022","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uniform Graft-versus-Host Disease Prophylaxis using Post-Transplantation Cyclophosphamide, Methotrexate, and Cyclosporine following Peripheral Blood Hematopoietic Stem Cell Transplantation from Matched and Haploidentical Donors for Transfusion-Dependent Thalassemia: A Retrospective Report from the Bone Marrow Failure Working Group of Hunan Province, China","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}